Skip to main
HTGM
HTGM logo

HTGM Earnings Dates & Reports

HTGM Most Recent Earnings

Report Date
Period EndingQ1 2023
Est. EPS-$1.94
Actual EPS-$2.28
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

HTGM Earnings per Share (EPS) History

Signup for full access
Browse free

HTGM Latest Earnings

The value each HTGM share was expected to gain vs. the value each share gained.

HTGM reported its most recent earnings on for Q1 2023, posting earnings per share (EPS) of -$2.28. This exceeded analysts' expectations of -$1.94 by 17.53%, marking a Miss.

For comparison, HTG Molecular Diagnostics reported EPS of -$9.72 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

HTGM Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2023
-$1.94-$2.28+17.53%
DeckReportListen
Q4 2022
-$1.79-$4.08+127.93%
DeckReportListen
Q3 2022
-$6.36-$4.92-22.64%
DeckReportListen
Q2 2022
-$7.20-$6.48-10.00%
DeckReportListen
Q1 2022
-$8.52-$9.72+14.08%
DeckReportListen
View all

HTGM Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the HTG Molecular Diagnostics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

HTGM Earnings FAQs

HTGM last reported earnings on May 10, 2023 for Q1 2023, posting an EPS of -$2.28, which Miss the estimate of -$1.94 by 17.53%.

For Q1 2023, HTGM reported an EPS of -$2.28, missing analysts' estimate of -$1.94 by 17.53%.

For Q1 2023, HTGM Miss expectations with an actual EPS of -$2.28 vs. an estimated EPS of -$1.94.

Following the last earnings report on May 10, 2023, HTGM's stock price moved — from — to —.

The next HTGM earnings call is scheduled for May. 10, 2023, where executives will discuss financial results and outlook.

HTG Molecular Diagnostics (HTGM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.